![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP RNS Number : 8719P GW Pharmaceuticals PLC 23 July 2010 GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company") NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS Porton Down, UK, 23 July 2010: GW Pharmaceuticals (AIM: GWP) hereby provides notification that the Company has today been notified that Richard Forrest, non-executive Director, has today purchased 20,000 ordinary shares of 0.1p each at the market price of 109 pence per share. This purchase equates to 0.015% of the issued ordinary share capital. Following this notification Richard Forrest's beneficial interest has increased to 60,000 ordinary shares, amounting to 0.046% of the shares in issue. The total number of shares outstanding in the Company is 130,041,372 ordinary shares of 0.1p each. For further information, please contact: GW Pharmaceuticals PLC +44 (0)1980 557 000 Adam George, Company Secretary Piper Jaffray Ltd (Nominated Adviser) Neil Mackison/Rupert Winckler +44 (0) 203 142 8700 This information is provided by RNS The company news service from the London Stock Exchange END RDSLLFIRDAIVFII
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions